Digest Network Come funziona
Network
/
Società
Vi
Non verificato

Viridian Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOtticaSalute

39 comunicati stampa

Guarda tutti i comunicati
05/12/2025
Mercato azionario
Finanza
Salute
Medicina - Varie
Scienza
Farmaceutica
Ottica
Biotecnologia
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Ottica
Biotecnologia
Mercato azionario
Finanza
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Web e Social Network
Eventi
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Ottica
Medicina - Varie
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
03/11/2025
Scienza
Biotecnologia
Farmaceutica
Ottica
Salute
Igiene alimentare
Medicina - Varie
Industria
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
22/10/2025
Finanza
Associazioni/Professionisti
Salute
Medicina - Varie
Farmaceutica
Ottica
Biotecnologia
Viridian Therapeutics Announces Pricing of $251 Million Public Offering of Shares of Common Stock
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
21/10/2025
Finanza
Biotecnologia
Salute
Farmaceutica
Ottica
Medicina - Varie
Viridian Therapeutics Announces Proposed Underwritten Public Offering
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
20/10/2025
Mercato del lavoro
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Ottica
Biotecnologia
Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2025
Salute
Scienza
Farmaceutica
Ottica
Biotecnologia
Mercato azionario
Finanza
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/09/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Ottica
Biotecnologia
Industria
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0
03/09/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Ottica
Biotecnologia
Mercato azionario
Finanza
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Viridian Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0